Views:

From 24 April 2023, pharmacy contractors can sign up to deliver the NHS Pharmacy Contraception Service Advanced Service.

A total of £900 will be paid in instalments:

  • £400 paid 30 days after signing up to deliver the service on MYS
  • £250 paid after claiming the first 5 consultations
  • £250 paid after claiming a further 5 consultations, up to a total of 10 consultations

You'll also receive a fee of £18 per consultation.

From 1 December 2023, the service expanded to include the initiation of oral contraception from a participating contractor. Contractors already delivering the ongoing supply must declare that they agree to the terms and scope of the extended service through the MYS portal by 23:59 on 29 February 2024.

If contractors wish to stop provision of the expanded service, they'll be de-registered 30 days after the declaration or by 1 March 2024 if less than 30 days. If a contractor does not make a declaration, they will be de-registered from the service on 1 March 2024 and will be notified.

The medicines that may be supplied as part of this service are listed in the Patient Group Direction (PGD). Only those medicines listed will be eligible for payment.

The cost of those medicines, if supplied as part of the service, will be reimbursed using the basic price in the Drug Tariff ‘Part II Clause 8 - Basic Price’.

The allowance for containers and consumables will not apply to products supplied as part of this advanced service.

No other elements of the Drug Tariff in relation to reimbursement of medicines apply to this service. An allowance at the applicable VAT rate will also be paid.

Claiming

Claims must be made by the 5th of the month. Payment will be made in the subsequent payment cycle.

Later submissions will be accepted, but only if made within three months of the date which the claim should have been submitted. Later claims will not be paid.

The service requirements for this service are set out in the NHS Pharmacy Contraception Service Specification.

Further information is available in the Drug Tariff.